- Home
- EXEL vs ODC Comparison
EXEL vs ODC Comparison
Compare EXEL & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | ODC |
|---|---|---|
| Founded | 1994 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 995.6M |
| IPO Year | 2000 | 1994 |
Fundamental Metrics
Financial Performance| Metric | EXEL | ODC |
|---|---|---|
| Price | $41.75 | $62.20 |
| Analyst Decision | Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $46.45 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 60.2K |
| Earning Date | 05-04-2026 | 06-19-2026 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | ★ 57.95 | 50.45 |
| EPS | ★ 2.78 | 1.69 |
| Revenue | $452,477,000.00 | ★ $485,572,000.00 |
| Revenue This Year | $13.66 | N/A |
| Revenue Next Year | $13.73 | N/A |
| P/E Ratio | ★ $15.12 | $36.75 |
| Revenue Growth | N/A | ★ 10.97 |
| 52 Week Low | $32.38 | $41.37 |
| 52 Week High | $48.74 | $70.01 |
Technical Indicators
Market Signals| Indicator | EXEL | ODC |
|---|---|---|
| Relative Strength Index (RSI) | 46.42 | 42.28 |
| Support Level | $40.01 | $60.61 |
| Resistance Level | $44.15 | $63.41 |
| Average True Range (ATR) | 1.23 | 2.78 |
| MACD | -0.08 | -0.81 |
| Stochastic Oscillator | 40.19 | 9.35 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.